Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alastair M Thompson

Showing results (161-170 of 195) with videos related to

Pageof 20
Sort By:
Journal of the National Cancer Institute|June 30, 2014
Therapeutic targeting of integrin αvβ6 in breast cancerKate M Moore, Gareth J Thomas, Stephen W Duffy, et al.
Cancers|July 14, 2023
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective TrialNour Abuhadra, Ryan Sun, Clinton Yam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III TrialSuzette Delaloge, Martine Piccart, Emiel Rutgers, et al.
JAMA Oncology|August 7, 2015
Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical TrialSimona F Shaitelman, Pamela J Schlembach, Isidora Arzu, et al.
Cell Metabolism|September 25, 2018
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast CancerSimon R Lord, Wei-Chen Cheng, Dan Liu, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 15, 2021
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast CancerBenjamin C Musall, Abeer H Abdelhafez, Beatriz E Adrada, et al.
Breast Cancer Research and Treatment|September 13, 2020
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)Abeer H Abdelhafez, Benjamin C Musall, Beatriz E Adrada, et al.
The Lancet. Oncology|March 15, 2021
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by ageMartine Piccart, Laura J van 't Veer, Coralie Poncet, et al.
Molecular Cell|August 18, 2018
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1Jong-Ho Cha, Wen-Hao Yang, Weiya Xia, et al.
The New England Journal of Medicine|August 25, 2016
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast CancerFatima Cardoso, Laura J van't Veer, Jan Bogaerts, et al.
Pageof 20

Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
Journal of the National Cancer Institute|June 30, 2014
Therapeutic targeting of integrin αvβ6 in breast cancerKate M Moore, Gareth J Thomas, Stephen W Duffy, et al.
Cancers|July 14, 2023
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective TrialNour Abuhadra, Ryan Sun, Clinton Yam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III TrialSuzette Delaloge, Martine Piccart, Emiel Rutgers, et al.
JAMA Oncology|August 7, 2015
Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical TrialSimona F Shaitelman, Pamela J Schlembach, Isidora Arzu, et al.
Cell Metabolism|September 25, 2018
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast CancerSimon R Lord, Wei-Chen Cheng, Dan Liu, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 15, 2021
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast CancerBenjamin C Musall, Abeer H Abdelhafez, Beatriz E Adrada, et al.
Breast Cancer Research and Treatment|September 13, 2020
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)Abeer H Abdelhafez, Benjamin C Musall, Beatriz E Adrada, et al.
The Lancet. Oncology|March 15, 2021
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by ageMartine Piccart, Laura J van 't Veer, Coralie Poncet, et al.
Molecular Cell|August 18, 2018
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1Jong-Ho Cha, Wen-Hao Yang, Weiya Xia, et al.
The New England Journal of Medicine|August 25, 2016
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast CancerFatima Cardoso, Laura J van't Veer, Jan Bogaerts, et al.
Pageof 20